Response to high-dose ifosfamide in patients with advanced/recurrent Ewing sarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Response to high-dose ifosfamide in patients with advanced/recurrent Ewing sarcoma

Published:2009-05 Issue:5 Volume:52 Page:581-584
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Ferrari S.,del Prever A. Brach,Palmerini E.,Staals E.,Berta M.,Balladelli A.,Picci P.,Fagioli F.,Bacci G.,Vanel D.

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference21 articles.

1. Ewing's sarcoma family of tumors: Current management;Bernstein;Oncologist,2006

2. Bone tumors in adolescents and young adults;Bielack;Curr Treat Options Oncol,2008

3. Localized Ewing tumor of bone: Final results of the cooperative Ewing's sarcoma study CESS 86;Paulussen;J Clin Oncol,2001

4. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone;Grier;N Engl J Med,2003

5. Long-term outcome for patients with non-metastatic Ewing's sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and1992;Bacci;Eur J Cancer,2004

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consensus recommendations for systemic therapies in the management of relapsed Ewing sarcoma: A report from the National Ewing Sarcoma Tumor Board;Cancer;2024-08-25

2. Clinical practice guidelines for the treatment of Ewing sarcoma (Spanish Sarcoma Research Group-GEIS);Clinical and Translational Oncology;2024-08-19

3. Regorafenib in patients with advanced Ewing sarcoma: results of a non-comparative, randomised, double-blind, placebo-controlled, multicentre Phase II study;British Journal of Cancer;2023-11-01

4. Ewing Sarcoma Drug Therapy: Current Standard of Care and Emerging Agents;Pediatric Drugs;2023-04-04

5. SELNET clinical practice guidelines for bone sarcoma;Critical Reviews in Oncology/Hematology;2022-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3